{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:38Z","timestamp":1794435938594,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["R01AI153064"],"award-info":[{"award-number":["R01AI153064"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["P01 AI097092-07"],"award-info":[{"award-number":["P01 AI097092-07"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["R01AI146101"],"award-info":[{"award-number":["R01AI146101"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["R01 AI145870-03"],"award-info":[{"award-number":["R01 AI145870-03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","award":["75N93021C00014"],"award-info":[{"award-number":["75N93021C00014"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102921","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:10:01Z","timestamp":1774930201000},"page":"102921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7920-5505","authenticated-orcid":false,"given":"Irene","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Boza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Abdeljawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Puente-Massaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitali","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsoi Ying","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieu","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Heyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Mart\u00ednez-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102921_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtn.2026.102921_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"Hannoun","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.omtn.2026.102921_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1071\/MA21033","article-title":"Influenza B viruses: underestimated and overlooked","volume":"42","author":"Koutsakos","year":"2021","journal-title":"Microbiology Australia"},{"key":"10.1016\/j.omtn.2026.102921_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00754-18","article-title":"The Influenza B Virus Hemagglutinin Head Domain Is Less Tolerant to Transposon Mutagenesis than That of the Influenza A Virus","volume":"92","author":"Fulton","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/fmb.15.120","article-title":"Knowns and unknowns of influenza B viruses","volume":"11","author":"Koutsakos","year":"2016","journal-title":"Future Microbiol."},{"key":"10.1016\/j.omtn.2026.102921_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0042-6822(90)90186-U","article-title":"Cocirculation of Two Distinct Evolutionary Lineages of Influenza Type B Virus since 1983","volume":"175","author":"Paul","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2026.102921_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211616119","article-title":"Substitutions near the HA receptor binding site explain the origin and major antigenic change of the B\/Victoria and B\/Yamagata lineages","volume":"119","author":"Rosu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102921_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.45.2400196","article-title":"Post-disappearance scenarios: policy implications following the potential disappearance of B\/Yamagata lineage influenza viruses","volume":"29","author":"Del Riccio","year":"2024","journal-title":"Euro Surveill."},{"key":"10.1016\/j.omtn.2026.102921_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41579-021-00642-4","article-title":"Influenza lineage extinction during the COVID-19 pandemic?","volume":"19","author":"Koutsakos","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.omtn.2026.102921_bib11","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.39.2200753","article-title":"Has influenza B\/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?","volume":"27","author":"Paget","year":"2022","journal-title":"Euro Surveill."},{"key":"10.1016\/j.omtn.2026.102921_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.omtn.2026.102921_bib13","first-page":"e01673","article-title":"Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans","volume":"93","author":"Sun","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib14","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JVI.02477-07","article-title":"Crystal Structure of Unliganded Influenza B Virus Hemagglutinin","volume":"82","author":"Qinghua","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib15","article-title":"Advances in Development and Application of Influenza Vaccines","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102921_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-med-120617-041310","article-title":"Is a Universal Influenza Virus Vaccine Possible?","volume":"71","author":"Nachbagauer","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtn.2026.102921_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00333-19","article-title":"Development of Influenza B Universal Vaccine Candidates Using the \u201cMosaic\u201d Hemagglutinin Approach","volume":"93","author":"Sun","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model","volume":"91","author":"Ermler","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-019-0126-4","article-title":"A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains","volume":"4","author":"Broecker","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.omtn.2026.102921_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4753","article-title":"Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice","volume":"9","author":"Puente-Massaguer","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102921_bib21","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102921_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"npj Vaccines"},{"key":"10.1016\/j.omtn.2026.102921_bib24","article-title":"A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study","volume":"6","author":"Nachbagauer","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2026.102921_bib25","article-title":"Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102921_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102921_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA Vaccines in the COVID-19 Pandemic and Beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtn.2026.102921_bib28","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102921_bib29","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41467-022-32149-8","article-title":"Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses","volume":"13","author":"Pardi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102921_bib30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206333119","article-title":"Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses","volume":"119","author":"McMahon","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102921_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41541-024-01014-8","article-title":"Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach","volume":"9","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.omtn.2026.102921_bib32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102921_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-0716-3770-8_7","article-title":"Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases","volume":"2786","author":"Vadovics","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102921_bib34","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/21645515.2018.1527496","article-title":"The effect of antigen dose on T cell-targeting vaccine outcome","volume":"15","author":"Billeskov","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.omtn.2026.102921_bib36","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"mRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.102921_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2336357","article-title":"Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines","volume":"20","author":"Russell","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.omtn.2026.102921_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.omtm.2021.06.003","article-title":"Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice","volume":"22","author":"Freyn","year":"2021","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102921_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1097349","article-title":"Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses","volume":"11","author":"Puente-Massaguer","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102921_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102921_bib41","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41565-025-01958-5","article-title":"Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications","volume":"20","author":"Vadovics","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102921_bib42","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","volume":"81","author":"Margine","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtn.2026.102921_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01185-20","article-title":"Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity","volume":"94","author":"Kirkpatrick","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102921_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105185","article-title":"Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice","volume":"105","author":"Slamanig","year":"2024","journal-title":"EBioMedicine"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:31:23Z","timestamp":1794432683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126000922"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102921","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza B mosaic HA mRNA-LNP vaccines are cross-reactive and protective in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102921"}}